How much funding has Hyfe raised?

Hyfe has raised $900K in total funding, most recently a Seed round.

Who are Hyfe's investors?

Hyfe's investors include Creative Destruction Lab, Alpha Intelligence Capital, Plug and Play, SPRIM Global Investments.

Where is Hyfe headquartered?

Hyfe is headquartered in Tokyo, United States.

Hyfe

End-to-end Cough: AI-powered respiratory care, from first symptoms to cure

Tokyo, United States · Founded 2020 · $900K raised

Healthcare

Headquarters: Tokyo
Employees: 11–50
Founded: 2020
Business Model: B2B2C

Website: hyfe.ai
Total Funding: $900K
Last Round: $900K SeedApr 2021
Rounds: 1

About

Hyfe is the global leader in AI-powered cough-monitoring technology. Founded in 2020, the company develops patented machine-learning software that enables passive, long-term monitoring of cough through smartphones and wearable devices. Hyfe's platform serves researchers, clinicians, and patients managing chronic respiratory conditions including chronic cough, asthma, and COPD. Its CoughPro app provides real-time cough tracking and community features, while its clinical-grade tools support pharmaceutical trials and digital therapeutics development.

Summary

Hyfe is a Healthcare company based in Tokyo, United States, founded in 2020. It has raised $900K in total across 1 round, most recently a $900K Seed round in Apr 2021. Investors include Creative Destruction Lab, Alpha Intelligence Capital and Plug and Play.